These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4020620)

  • 1. Binding and disposition of sulfisoxazole in alcoholic cirrhosis.
    Cello JP; Oie S
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):1-12. PubMed ID: 4020620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cimetidine disposition in patients with Laennec's cirrhosis during multiple dosing therapy.
    Cello JP; Oie S
    Eur J Clin Pharmacol; 1983; 25(2):223-9. PubMed ID: 6628505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the disposition of total and unbound sulfisoxazole after single and multiple dosing.
    Oie S; Gambertoglio JG; Fleckenstein L
    J Pharmacokinet Biopharm; 1982 Apr; 10(2):157-72. PubMed ID: 7120046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of serum protein binding on sulfisoxazole distribution, metabolism, and excretion in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1979 Jun; 68(6):742-6. PubMed ID: 458578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of sulfisoxazole in renal transplant patients.
    Shermantine M; Gambertoglio J; Amend W; Vincenti F; Oie S
    Antimicrob Agents Chemother; 1985 Oct; 28(4):535-9. PubMed ID: 3907496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of sulfisoxazole in young and elderly subjects.
    Boisvert A; Barbeau G; Bélanger PM
    Gerontology; 1984; 30(2):125-31. PubMed ID: 6706125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naproxen disposition in patients with alcoholic cirrhosis.
    Williams RL; Upton RA; Cello JP; Jones RM; Blitstein M; Kelly J; Nierenburg D
    Eur J Clin Pharmacol; 1984; 27(3):291-6. PubMed ID: 6510456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiopental pharmacokinetics in patients with cirrhosis.
    Pandele G; Chaux F; Salvadori C; Farinotti M; Duvaldestin P
    Anesthesiology; 1983 Aug; 59(2):123-6. PubMed ID: 6869869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine disposition in severe hepatic cirrhosis.
    Gonzalez-Martin G; Paulos C; Veloso B; Chesta J; Novoa X; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):139-42. PubMed ID: 3557740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlordiazepoxide and oxazepam disposition in cirrhosis.
    Sellers EM; Greenblatt DJ; Giles HG; Naranjo CA; Kaplan H; MacLeod SM
    Clin Pharmacol Ther; 1979 Aug; 26(2):240-6. PubMed ID: 455893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired elimination of caffeine in cirrhosis.
    Desmond PV; Patwardhan RV; Johnson RF; Schenker S
    Dig Dis Sci; 1980 Mar; 25(3):193-7. PubMed ID: 7371463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and protein binding of cefpiramide in patients with alcoholic cirrhosis.
    Demotes-Mainard F; Vinçon G; Amouretti M; Dumas F; Necciari J; Kieffer G; Begaud B
    Clin Pharmacol Ther; 1991 Mar; 49(3):263-9. PubMed ID: 2007321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis.
    Owen OE; Trapp VE; Reichard GA; Mozzoli MA; Moctezuma J; Paul P; Skutches CL; Boden G
    J Clin Invest; 1983 Nov; 72(5):1821-32. PubMed ID: 6630528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein binding and metabolic clearance of phenytoin in the rat.
    Colburn WA; Gibaldi M
    J Pharmacol Exp Ther; 1977 Dec; 203(3):500-6. PubMed ID: 925955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temazepam clearance unaltered in cirrhosis.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B; Matlis R
    Am J Gastroenterol; 1986 Jan; 81(1):80-4. PubMed ID: 2867675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine clearance is impaired in alcoholic cirrhosis.
    Leighton JA; Bay MK; Maldonado AL; Schenker S; Speeg KV
    Hepatology; 1991 Dec; 14(6):1013-5. PubMed ID: 1959847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of protein binding and metabolic interconversion on the disposition of sulfisoxazole and its N4-acetyl metabolite by the isolated perfused rat kidney.
    Bekersky I; Popick AC; Colburn WA
    Drug Metab Dispos; 1984; 12(5):607-13. PubMed ID: 6149912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Furosemide disposition in cirrhosis.
    Verbeeck RK; Patwardhan RV; Villeneuve JP; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1982 Jun; 31(6):719-25. PubMed ID: 7075120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of hepatic cirrhosis on the plasma protein binding of drugs.
    García-Morillas M; Gil-Extremera B; Caracuel-Ruiz MD
    Int J Clin Pharmacol Res; 1984; 4(5):327-33. PubMed ID: 6519849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.